Koninklijke DSM NV (Koninklijke DSM NV) Debt-to-Equity : 0.29 (As of Dec. 2022)

View and export this data going back to . Start your Free Trial

What is Koninklijke DSM NV Debt-to-Equity?

Koninklijke DSM NV's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $91 Mil. Koninklijke DSM NV's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $3,155 Mil. Koninklijke DSM NV's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $11,380 Mil. Koninklijke DSM NV's debt to equity for the quarter that ended in Dec. 2022 was 0.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Koninklijke DSM NV's Debt-to-Equity or its related term are showing as below:

KDSKF's Debt-to-Equity is not ranked ^*
in the Chemicals industry.
Industry Median: 0.35
* Ranked among companies with meaningful Debt-to-Equity only.

Koninklijke DSM NV Debt-to-Equity Historical Data

The historical data trend for Koninklijke DSM NV's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke DSM NV Debt-to-Equity Chart

Koninklijke DSM NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.34

0.49

0.33

0.29

Koninklijke DSM NV Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Debt-to-Equity	Get a 7-Day Free Trial															0.49	0.37	0.33	0.32	0.29

Competitive Comparison of Koninklijke DSM NV's Debt-to-Equity

For the Specialty Chemicals subindustry, Koninklijke DSM NV's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Koninklijke DSM NV's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Koninklijke DSM NV's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Koninklijke DSM NV's Debt-to-Equity falls into.

Koninklijke DSM NV Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Koninklijke DSM NV's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(91.102	+	3154.661)	/	11380.297
	=	0.29

Koninklijke DSM NV's Debt to Equity Ratio for the quarter that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(91.102	+	3154.661)	/	11380.297
	=	0.29

Koninklijke DSM NV (OTCPK:KDSKF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Koninklijke DSM NV Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Koninklijke DSM NV's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Koninklijke DSM NV (Koninklijke DSM NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Koninklijke DSM NV (OTCPK:KDSKF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Het Overloon 1, P.O. Box 6500, Heerlen, LI, NLD, 6411 TE

Website

https://www.dsm.com

Koninklijke DSM NV is a global, purpose-led company in Health, Nutrition, and Bioscience, applying science to improve the health of people, animals, and the planet. The company delivers innovative business solutions for human and animal nutrition, personal care and aroma, medical devices, green products and applications, new mobility, and connectivity. The company's segment includes Animal Nutrition & Health (ANH), Health, Nutrition & Care (HNC), and Food & Beverage (F&B), where the majority of its revenue is generated from Animal Nutrition & Health (ANH).